Related Experiment Video
Updated: Dec 20, 2025

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
Published on: February 17, 2018
Ventricular Tachycardia in Structural Heart Disease
Eliany Mejia Lopez1, Rohit Malhotra1
1Cardiac Electrophysiology Department, Cardiovascular Division, Department of Medicine, University of Virginia Health System, Charlottesville, VA, USA.
Insights
Managing ventricular tachycardia (VT) in structural heart disease (SHD) often requires a combination of therapies. This review discusses current treatment options for VT in SHD patients, focusing on diagnosis and management strategies.
Area of Science:
- Cardiology
- Electrophysiology
- Internal Medicine
Background:
- Structural heart disease (SHD) poses a significant risk for ventricular tachycardia (VT), a challenging clinical management problem.
- Coronary artery disease with myocardial infarction (MI) is the most frequent cause of SHD-associated VT, primarily due to scar-mediated reentry.
- Other conditions like cardiomyopathies and congenital heart disease also contribute to VT in SHD.
Purpose of the Study:
- To review current therapeutic strategies for managing ventricular tachycardia in patients with structural heart disease.
- To highlight the importance of accurate diagnosis and mechanism identification for guiding treatment decisions.
- To discuss the role and limitations of antiarrhythmic drugs and catheter ablation.
Main Methods:
- Review of existing literature on ventricular tachycardia management in structural heart disease.
- Analysis of diagnostic approaches including patient history, ECG, and imaging.
- Evaluation of therapeutic options such as antiarrhythmic drugs and catheter ablation.
Main Results:
- No single treatment guarantees perfect results; combination therapy is often necessary for effective VT control.
- Accurate diagnosis and localization of VT origin are crucial for successful catheter ablation.
- Antiarrhythmic drugs may reduce VT burden but do not improve mortality and can worsen heart failure.
Conclusions:
- Effective management of VT in SHD necessitates a comprehensive approach integrating diagnostic findings with therapeutic interventions.
- Catheter ablation is a key option when indicated, guided by precise arrhythmia localization.
- Careful consideration of antiarrhythmic drug risks, particularly negative inotropic effects, is essential.
Abstract:
Patients with structural heart disease (SHD) are at risk of ventricular tachycardia (VT), which can be difficult to manage clinically. Many treatment options are currently available, but no single approach can be applied with 100% perfect results; often, a combination of therapies is required to achieve good control of ventricular arrhythmias. Coronary artery disease with previous myocardial infarction (MI) is the most common form of SHD presenting with VT, with scar-mediated reentry being the predominant mechanism. Other cardiomyopathies such as arrhythmogenic right ventricular cardiomyopathy, sarcoidosis, Chagas disease, and repaired congenital heart disease can also present in conjunction with ventricular arrhythmias. A thorough analysis of the patient's history, 12-lead electrocardiogram, and imaging findings are essential for understanding the mechanism and guiding localization of the site of origin of the arrhythmia and the presence of underlying heart disease, which will improve outcomes following catheter ablation if such is indicated. Separately, antiarrhythmic drugs have not been shown to decrease mortality in this patient population but can help to reduce the VT burden and subsequently the need for implantable cardioverter-defibrillator therapy. Unfortunately, most antiarrhythmic agents are negative inotropes, with the possibility of worsening heart failure. This review aims to discuss the current options available for the management of VT in SHD.
More Related Videos
06:57Ablation of Ischemic Ventricular Tachycardia Using a Multipolar Catheter and 3-dimensional Mapping System for High-density Electro-anatomical Reconstruction
Published on: January 31, 2019
12:15Tissue Preparation Techniques for Contrast-Enhanced Micro Computed Tomography Imaging of Large Mammalian Cardiac Models with Chronic Disease
Published on: February 8, 2022
Related Concept Videos
Dysrhythmias III: Characteristics of Dysrhythmias
Dysrhythmias II: Classification of Tachyarrhythmias
Increased pulse rate
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Mechanism of Cardiac Arrhythmias
Dysrhythmias IV: Characteristics of Bradyarrhythmias